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Abstract.  Heavy chain-binding protein (BiP)  associ- 
ates posttranslationally with nascent Ig heavy chains in 
the endoplasmic reticulum (ER) and remains as- 
sociated with these heavy chains until they assemble 
with light chains. The heavy chain-BiP complex can i 
be precipitated by antibody reagents against either 
component. To identify sites on heavy chain molecules 
that are important for association with BiP, we have 
examined 30 mouse myelomas and hybridomas that 
synthesize Ig heavy chains with well characterized de- 
letions. Mutant Ig heavy chains that lack the C,1  do- 
main could not be demonstrated to associate with BiP, 
whereas mutant Ig heavy chains with deletions of the 
CH2 or CH3 domain were still able to associate with 
BiP. In two light chain negative cell lines that pro- 
duced heavy chains with deletions of the CH1  domain, 
free heavy chains were secreted. When Ig assembly 
and secretion were examined in mutants that did not 
associate with BiP, and were compared with normal 
parental lines, it was found that the rate of Ig secretion 
was increased in the mutant lines and that the Ig 
molecules were secreted in various stages of assembly. 
In one mutant line (CH1-) approximately one-third of 
the secreted Ig molecules were incompletely assem- 
bled, whereas the Ig molecules secreted by the paren- 
tal line were completely assembled. Our data show the 
CH1 domain to be important for association with BiP 
and that when this association does not occur, incom- 
pletely assembled heavy chains can be secreted. This 
implies a role for BiP in preventing the transport of 
unassembled Ig molecules from the ER. 
I 
MMUNOGLOBULIN biosynthesis,  assembly,  and  trans- 
port have been well characterized using both normal and 
malignant lymphoid  cells  (7, 27). The Ig molecule  is 
composed  of two  identical  heavy chain proteins  and two 
identical light chain (LC) t proteins which are joined by in- 
terchain disulfide bonds. Nascent heavy and light chains con- 
tain a hydrophobic amino-terminal signal sequence which al- 
lows them to be cotranslationally translocated into the lumen 
of the endoplasmic reticulum (ER) (5). The addition of man- 
nose core sugars to heavy chains occurs during this translo- 
cation  (4). Very soon after translocation,  heavy and light 
chains begin to assemble in the ER and interchain disulfide 
bonds are formed (24, 27). The sequence of subunit assem- 
bly appears to be determined by the heavy chain isotype. IgM 
and  some IgG2b assemble  as heavy and light  chain  (HL) 
molecules and then H2~ molecules, whereas IgGt and IgGz, 
first form H2 molecules, then H2L, and finally intact H2L2 
molecules (3). Once assembly is complete, the Ig molecule 
is transported to the Golgi complex for further processing of 
1. Abbreviations used in this paper: BiP, heavy chain-binding protein; ER, 
endoplasmic  reticulum;  LC, light chain; HCD,  lymphoproliferative  heavy 
chain disease; HL, heavy and light chain. 
its carbohydrate side chains (14). The mechanism for direct- 
ing the Ig molecule to Golgi is not well understood.  Data 
gathered from studying the transport of other proteins to the 
Golgi complex suggest the existence of inherent transport 
signals on protein molecules which direct their transport to 
the Golgi complex (10, 20).  It is not clear if transport  se- 
quences are present on the heavy chain, the light chain, or 
both. After processing in the Golgi complex, the Ig molecule 
is packaged into vesicles that are targeted to the plasma mem- 
brane for secretion. 
Usually,  only completely  assembled  Ig  molecules  are 
secreted. When assembly can not occur due to the absence 
of light chain  synthesis or is  inhibited due  to the  under- 
glycosylation of heavy chains in the case of IgM, the free 
heavy chains are not transported to the Golgi complex and 
are degraded internally (13, 17). A notable exception to this 
occurs in lymphoproliferative heavy chain disease (HCD). 
This disorder is characterized by the production and secre- 
tion of heavy chains in the absence of LC production (11). 
The secreted heavy chains are abnormal in that they contain 
large protein deletions that usually involve the first constant 
region domain (CH1) and occasionally the variable region 
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lines that synthesize and secrete heavy chains without LC. 
Like the proteins produced in HCD, these heavy chains also 
have deletions of the CH 1 domain (8, 21). 
Heavy chain-binding protein (BiP) has been demonstrated 
to coprecipitate with heavy chains synthesized in myeloma 
lines, that have lost the ability to sythesize LC (6, 23), and 
in  Abelson  virus  transformed pre-B  cell  lines  (Ix  +,  LC-) 
(12). We have found BiP to be part of the normal posttransla- 
tional processing of Ig heavy chains (6). BiP associates with 
nascent heavy chains in the lumen of the ER and appears to 
be dissociated only when  LC are added to heavy chains. 
When LC are not synthesized, BiP remains associated with 
heavy chains and these heavy chains are not transported to 
the Golgi or secreted (6).  When IgM-producing cells are 
treated with tunicamycin, the unglycosylated Ix-chains do not 
combine with LC efficiently, are not secreted (13), and re- 
main  associated  with BiP  (Hendershot,  L.,  D.  Bole,  and 
J.  E  Kearney, manuscript  submitted  for publication).  We 
have proposed that BiP acts to hold heavy chains in the ER 
until assembly is complete by interfering with or blocking 
transport  sequences on heavy chains.  Only after BiP has 
been dissociated would the transport sequences on heavy 
chains be exposed. 
To determine which portions of the heavy chains are in- 
volved in  the association  with BiP,  we examined deletion 
mutants lacking different CH domains.  If mutant Ig heavy 
chains could be found that did not associate with BiP we 
could more directly determine how BiP affects Ig assembly 
and secretion. Thirty mouse lymphoid cell lines that produce 
heavy chains with well characterized deletions were exam- 
ined for the ability of their heavy chains to associate with 
BiP. The CH 1 domain was found to be necessary for the as- 
sociation  of  tx,  "/1, "/2a, and  )'2b heavy  chains  with  BiP. 
Heavy chains,  which did not associate with BiP,  could be 
secreted in the absence of LC synthesis. Cell lines that syn- 
thesized LC together with heavy chains with CH1  domain 
deletions  secreted completely assembled  Ig  molecules as 
well as all the assembling intermediates. 
Materials and Methods 
Cell Lines 
The cell lines used in this study were obtained from a variety of sources. 
Most have been described previously and are summarized in Table I. Cell 
lines 45.6 (21), 10.1 (21), G403 (21), RI5 (8), A15 (8), and K25.1 (22) were 
a gift from Dr. S. Morrison (Columbia University, New York).  Cell lines 
Ar13.4  (29),  ArMI6 (29),  ArMI  (29),  S107 (30),  SIU9 (30),  RP3,  RP4, 
th3, 24F3, 26C2, 6C4, 16D2, 21)1312, and 3G3 were gifts from Drs. R. Pol- 
lack and M. D. Scharff (Albert Einstein College of Medicine, New York). 
Cell lines PC 700 (2), 562 (2), and 574 were a gift from Dr. M. Shulman 
(University of Toronto).  Cell lines 208 (2), 482 (18), 662 (18), and RD3-2 
(6) have been described previously. LBW-26  is a human Epstein-Barr Vi- 
rus-transformed cell line which synthesizes IgG and was produced in this 
lab. All lines were maintained in RPMI 1640 with 10% FBS, 2 mM L-gluta- 
mine, and 100 U/ml penicillin-streptomycin. 
Biosynthetic Labeling 
For short pulse and pulse-chase experiments, the cells were pre-incubated 
in RPMI 1640 lacking methionine for l h and then labeled with 25 ~tCi of 
[35S]methionine  (Amersham Corp.,  Arlington Heights,  IL)  for  10  rain. 
When chase experiments were performed, cells were resuspended in com- 
plete RPMI 1640 devoid of radioactive methionine and incubated for indi- 
cated times. For continuous labeling experiments, cells were placed directly 
in  methionine-free RPMI  1640 containing  25  IxCi [3SS]methionine  and 
labeled for 90 min. 
Immunoprecipitation 
Labeled cells were harvested and  lysed in half-strength PBS containing 
0.5 % deoxycholic acid and 0.5 % NP-40. Nuclei were sedimented at 10,000 g 
for 20 rain and the resulting supernatant was used for immunoprecipitation. 
Anti-mouse isotype specific antibodies were obtained from Southern Bio- 
technology Associates (Birmingham, AL).  The rat anti-BiP monoclonal 
(IgGx) was produced in this laboratory and has been described previously 
(6).  A mouse anti-rat K monoclonal antibody (26) was conjugated directly 
to Sepharose 4B beads and was used to precipitate the anti-BiP monoclonal. 
Anti-mouse isotype antibodies were precipitated by binding to Protein A 
conjugated Sepharose 4B beads. Immunoprecipitated proteins were washed 
three times with 0.05 M Tris buffer, pH 7.4, containing 0.4 M NaCI, 0.5% 
DOC, and 0.5 % NP40, and analyzed by SDS PAGE (19). The SDS gels were 
then fluorographed using En3Hance (New England Nuclear, Boston, MA), 
dried, and exposed on Kodak XAR-5 film to visualize bands. 
Results 
Reactivity of lgGzb Mutant Proteins with BiP 
Five IgG2b-producing  cell lines were examined for the abil- 
ity of their heavy chains to associate with BiP posttransla- 
tionally. Ar13.4 cells produce antibody with specificity for 
arsonate and contain complete ~2b heavy chains (29).  Two 
mutant sublines of Ar13.4  with domain-spanning deletions 
were obtained:  ARM16, which is missing the CH2 domain, 
and ARM1, which has deleted the CH3 domain of its heavy 
chain  (29).  45.6  cells,  which  are  the  tissue  culture  line 
equivalent of the  myeloma MPC  11,  and  its  subline  10.1, 
which synthesizes and secretes IgG2b antibodies lacking the 
C.1 domain (21), were also examined. The cells were pulse 
labeled with [35S]methionine  and then lysed. The cell lysate 
was divided and one half was  precipitated with anti-IgG2b 
and the other half with anti-BiP antibodies. A major band 
representing heavy chains can be observed from each cell 
line when precipitating with anti-Ig (Fig.  1). The molecular 
weight of the heavy chains from each cell line vary according 
to  whether  they contain  a  deletion  and  which  domain  is 
deleted.  A  fainter band  comigrating with BiP can be ob- 
served in the anti-Ig precipitated material from the Ar13.4, 
ARM16, and ArM1 clones. We were unable to detect any BiP 
coprecipitating with Ig in the 45.6 cell line. This could be due 
Figure 1.  Ar13.4, ArMI6, ARM1, 45.6, and  10.1 cells were pulse la- 
beled with  [35S]methionine for  10 min.  Cell lysates were divided 
and  one half was precipitated with  anti-IgG2b and  the other half 
with anti-BiP. The immunoprecipitates were analyzed on 10% SDS 
PAGE under reducing conditions. 
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the case of ArM1 and slightly faster than BiP in the case of 
ARM16. These do not appear to be alternate forms of BiP as 
they are not precipitated with anti-BiP. It is possible that they 
represent some incompletely reduced IgG:b. When each of 
the lysates were immunoprecipitated  with anti-BiP,  a  band 
migrating at 78 kD was obtained.  In both of the parent lines 
(Ar13.4 and 45.6), normal ~/heavy chains coprecipitated with 
BiP (Fig. 1). Examination of the mutant sublines showed that 
the heavy chains missing the C.2 and C.3 domains (ARM16 
and  ARM1)  were  also  coprecipitated  with  BiP.  However, 
heavy chains lacking the CH1 domain from the 10.1 subline 
were not coprecipitated with BiP. Therefore, deletions of the 
C.2 or C.3 domain did not appear to affect significantly the 
association of Y:b heavy chains with BiP whereas the C,1 
domain seemed to be necessary for this  association. 
Figure 2.  S107, S~Ug, and A15 ceils  were pulse labeled  for 10 rain 
with [3~S]methionine. Cell lysates were divided  and one half was 
precipitated  with  anti-IgA and the other half with  anti-BiP.  The 
precipitated  proteins  were  analyzed on  10%  SDS  PAGE under 
reducing conditions. 
to the fact that Ig in this cell line also assembles  along the 
H  ~  HL ~  H2L2 pathway,  thus  leaving  fewer free heavy 
chains to associate with BiP. It is also possible that this line 
has a larger unlabeled intracellular pool of BiP which is as- 
sociating with the ~'2b heavy chains.  In the anti-IgG2b pre- 
cipitated material from both ARM16 and ARM1, a faint band 
Association of  Mutant IgA Heavy Chains with BiP 
Three IgA-producing lines were examined for the ability of 
their heavy chains to associate with BiP.  S107 cells produce 
IgA immunoglobulin with specificity for phosphorylcholine 
(30).  $1U9 is a subline of S107 and produces ¢t heavy chains 
which lack the C.3 domain. The A15 line,  which produces 
a  heavy chains  missing  the  Crd  domain,  is  a  subline  of 
W3129 which recognizes al --" 6 dextran (8). The cells were 
pulse  labeled  and  immunoprecipitated  with  anti-IgA  or 
anti-BiP antibodies.  The ct heavy chains were precipitated 
from each of the cell lines with anti-IgA (Fig. 2).  When ly- 
sates were immunoprecipitated with anti-BiP, BiP could be 
precipitated from each of the cell lines.  In the case of Sift/ 
and $1U9 (C.3-) cells,  a  heavy chains were coprecipitated 
with BiP.  However,  no a  heavy chains  from the  AI5 cells 
(C.1-)  could  be  demonstrated  to  coprecipitate  with  BiP 
(Fig. 2). Therefore, as in the Y2b heavy chains, the CH1 do- 
main appeared to be necessary for the association of a  heavy 
Table I. Summary of  Mutant Cell Lines and Their Reactivity with BiP 
Reactivity 
Cell lines  Isotype  Parent line  Deletion  Assembly  with BiP 
Ar13.5  (29)  IgG2b  --  --  H2L2  + 
ArMI6 (29)  IgG2b  Ar13.5  CH2  H2L2  + 
ArM1 (29)  IgG2b  Arl3.5  CH3  HL  + 
45.6 (21)  IgG~b  MPCI 1  -  H2L2  + 
10.1 (21)  IgG2b  45.6  CHIn  H2L2(noncov L)  - 
G403 (21)  IgG2b  10.1  CH,  +  LC-  H  - 
S107 (30)  IgA  -  -  H2lm(noncov L)  + 
S,Ug (30)  IgA  S107  CH3  HL  + 
W3129 (8)  IgA  -  -  H2lm(noncov L)  + 
R15 (8)  IgA  W3129  LC-  H2  "t- 
A15 (8)  IgA  R15  CH1 +  LC-  H  - 
RP3  IgG~  3665  -  nEE2  "t- 
RP4  IgG,  RP3  CH2  H2L2  + 
24F3  IgG,  3665  CH3  HzI-a  + 
26C2  IgGi  3665  CH2  H2I-,z  + 
th3  IgGj  3665  CH~  H2L2(noncov L)  - 
AgS(8) (6)  IgGj  P3X63Ag8  LC-  n 2  .-0- 
K25.1 (22)  IgG2b  --  --  H2L2(noncov L)  - 
PC700 (2)  IgM  -  -  (H21~)5  + 
208 (2)  IgM  PC 700  CH1_3  HL  - 
562 (2)  IgM  PC 700  Carboxyterm  H2~  + 
574 (31)  IgM  PC 700  LC  H2  + 
482 (18)  IgM  Sp6  CH3.*  H2L2  "t" 
662 (18)  IgM  Sp6  CH3-4  H2L2  + 
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chain did not appear to affect this association. 
Summary of  Mutant Cell Lines 
and Their Reactivity with BiP 
Altogether 30 mouse myeloma and hybridoma cell lines, in- 
cluding 6  cell lines producing IgG2b, 4  producing IgA,  1 
producing  IgG2a, 10  producing  IgG~,  and  9  synthesizing 
IgM, were examined for association of heavy chains with BiP 
(Table I). The Ig subclass, degree oflg assembly, and the ex- 
tent of  the heavy chain deletion for each line has been charac- 
terized previously and are summarized in Table I. For most 
of the  isotypes,  Lines were obtained that produced heavy 
chains with deletions of each of the Ca domains.  Six cell 
lines were found that produced heavy chains that did not as- 
sociate  with  BiP  as judged by the  inability  of anti-Ig  to 
coprecipitate BiP or anti-BiP to coprecipitate heavy chains. 
These  included two  cell  lines  that  synthesized T2b heavy 
chains, one cell line making 71 heavy chains, one producing 
72a heavy chains, one synthesizing ¢t heavy chains, and one 
producing Ix heavy chains. In each case these heavy chains 
lacked the Cal  domain. The deletion of other Ca domains 
did not appear to affect the posttranslational association of 
BiP with heavy chains. 
Association of BiP with Heavy Chains in LC- Lines 
Four cell lines that produce heavy chains but do not synthe- 
size LC (H  +, LC-) were examined for posttranslational as- 
sociation of heavy chains with BiP and heavy chain secre- 
tion.  AgS(8) (71  +,  LC-) and 574 (IX+, LC-) cells produce 
complete heavy chains that are not secreted (6, 28a). The AI5 
(a  +, LC-) and G403 (72b  +, LC-) cells produce heavy chains 
that lack the CH1 domain and are secreted in the absence of 
LC synthesis (8, 21). The cell lines were labeled for 90 min 
and after harvesting, both cell lysates and culture superna- 
tants were analyzed. Cell lysates were immunoprecipitated 
with either anti-heavy chain isotype specific or anti-BiP an- 
Figure 3.  Ag8(8) d(~q), 574 (IlL A15 0x), and G403 ('~2b) cells 
were labeled for 90 min with 25 I.tCi of [35S]methionine. Cell ly- 
sates were split  and immunoprecipitated with  either  anti-heavy 
chain specific antibodies or anti-BiP. Culture supematants were im- 
munoprecipitated with anti-heavy chain-specific antibodies to de- 
tect any secreted heavy chains. Precipitated proteins were analyzed 
on 10% SDS PAGE under reducing conditions. 
tibodies, and the culture supernatants were precipitated with 
anti-isotype specific antibodies. Anti-heavy chain precipi- 
tation of Ag8(8) and 574 cell lysates resulted in the precipi- 
tation of y~ and  ~t heavy chains,  respectively, as  well as 
coprecipitation of BiP (Fig.  3).  Anti-BiP precipitation of 
these cell lysates demonstrated two bands: one representing 
BiP and the other representing y1 heavy chains in the case 
of Ag8(8) cells and IX in the case of 574 cells.  The heavy 
chains were not secreted from these cells as determined by 
our inability to precipitate them from the culture superna- 
tants (Fig. 3). When A15 and G403 cells were analyzed in the 
same manner, the anti-heavy chain antibodies were shown 
to  precipitate  only  tx  heavy  chains  (A15)  or  y2b-heavy 
chains (G403). We were unable to detect any coprecipitating 
BiP in either of these lines. Likewise, anti-BiP precipitated 
only BiP from A15 and G403 cells with no coprecipitating 
bands representing ¢t or 72b heavy chains. When culture su- 
pernatants from these two lines were examined for the secre- 
tion of heavy chains,  Cal-deleted tx chains,  in the case of 
A15 cells, and C.l-deleted 72b chains,  in the case of G403 
cells,  could be found (Fig.  3).  These experiments suggest 
that the secretion of free heavy chains occurs when the heavy 
chains fail to associate with BiP. 
Assembly of Secreted Ig Molecules in CM- Mutant 
Secreted Ig from a cell line producing T heavy chains with 
a CH 1 domain deletion was compared with normal secreted 
IgG to determine if the inability of heavy chains to associate 
with BiP affected their assembly and  secretion.  Four cell 
lines that produce normal Y  heavy chains as well as 10.1 cells, 
which produce Y heavy chains with a CH1 domain deletion, 
were labeled for 2 h. The culture supernatant was immuno- 
precipitated with anti-Ig  and  analyzed under nonreducing 
conditions by SDS PAGE. The four cell lines that synthesize 
normal Y  heavy chains secreted them as completely polymer- 
ized H2L2 molecules (Fig. 4 a, Ig). When secreted Ig from 
the 10.1 cell line was examined in the same manner, three ma- 
jor bands were precipitated with anti-Ig (Fig. 4 a, Ig). They 
represent H2, H, and LC molecules. This agrees with pre- 
viously reported data on this cell line (21). 
When the CH1 domain is missing, LC are attached to the 
CH2  or  Cn3  domain  of the  heavy  chain  by  noncovalent 
bonds  (21).  After  SDS  denaturation  of these noncovalent 
bonds, it was impossible to tell if the HE band was derived 
from HEL2, HEL, H2 molecules, or all three and whether the 
H band came from H or HL molecules (Fig. 4 b). To clarify 
this, the labeled culture supernatant from 10.1 cells was first 
immuno-absorbed with monoclonal anti-v: conjugated seph- 
arose beads to precipitate all LC-containing molecules. The 
remaining Ig molecules (H and HE) were then precipitated 
with anti-Ig. When the precipitated material was examined 
by SDS PAGE, we found that the anti-v: antibody precipi- 
tated all of the LC band, all of the H band (HL), and about 
half of the H2 band (H2L2, H2L) (Fig. 4 a, k'). The remain- 
ing H2 molecules were precipitated with anti-Ig (Fig. 4  a, 
Ig'). Therefore, the three bands shown in the secreted mate- 
rial from 10.1 cells represent H2L2, HEL, H2, HL, and LC 
molecules. When th3 (Y1, CH1-)  and K25 cells (72~, CH1-) 
were examined in the same way, they were also found to se- 
crete unassembled Ig molecules (data not shown). 
This demonstrates that in the absence of posttranslational 
association with BiP, heavy chains and all of the assembly 
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Figure 5.  45.6 cells (a) and 10.1 cells (b) were pulse labeled for 10 
min with  [35S]methionine, resuspended  in complete RPMI 1640, 
and chased for 0, 15, 30, 60, and 120 min. Cell lysates and culture 
supernatants were immunoprecipitated  with anti-Ig and analyzed on 
10%  SDS  PAGE under reducing conditions.  The y heavy chains 
from each time point on the autoradiograph were quantitated  by 
densitometer  tracing and are represented  as percent of cell-asso- 
ciated  heavy chains at t  =  0. 
Figure 4. (a) Four cell lines producing normal y heavy chains (26, 
Ar13.4, RD3, and 45.6) and one cell line producing y heavy chains 
with a CM1 domain deletion (10.1) were labeled  for 2 h with [35S]- 
methionine.  Culture supernatants  were precipitated with anti-Ig and 
separated on 8% SDS PAGE under nonreducing conditions (Ig). To 
determine the identity of the three bands precipitated  from the 10.1 
cells,  the  supernatant  was  reacted  first  with  anti-K  (lane  k') to 
precipitate  LC-containing  molecules,  followed  by  precipitation 
with  anti-Ig (lane  lg') to isolate  remaining heavy chains.  (b)  A 
intermediates of Ig are secreted.  This is in direct contrast to 
heavy chains containing the CH1 domain that associate with 
BiP  and  are  not  secreted  except  as  completely  assembled 
molecules 
Rate of  Secretion of lg in the Absence 
of  Association with BiP 
To  determine  whether  the  association  of BiP  with  heavy 
chains  affected  the  rate  of Ig transport,  the  kinetics  of Ig 
secretion were examined in 10.1 cells (CH1-) and the parent 
line 45.6.  Cells were pulse labeled with [35S]methionine for 
15 min and  chased for 0,  15,  30,  60,  and  120 min.  Ig was 
schematic drawing to show the assembly of Ig molecules when the 
CH1  domain is missing,  and the gel patterns  observed when this 
molecule is analyzed on SDS PAGE under nonreducing conditions. 
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tants.  Immunoprecipitated proteins were analyzed by SDS 
PAGE, and cellular and secreted Ig was quantitated by den- 
sitometer  tracings  of  the  autoradiograph.  Densitometer 
tracings of each time point were calculated as percent of cell- 
associated heavy chain at t =  0 (Fig. 5, a and b). The t,~ for 
transport of heavy chains from the 45.6 cells was calculated 
to be 100 min, whereas the t,~ for transport of heavy chains 
from  10.1 cells was  only 50 min.  The CHI- heavy chains 
from the  10.1 cells that  did not associate with  BiP were 
secreted at twice the rate of their normal counterparts syn- 
theized by 45.6 cells, which do associate with BiP. 
Discussion 
In this study we have compared the posttranslational associa- 
tion of mutant and wild type heavy chains with BiP. Six cell 
lines were found which produced heavy chains that did not 
appear to associate with BiP as judged by the inability of anti- 
Ig to coprecipitate BiP or anti-BiP to coprecipitate heavy 
chains. These cell lines produced heavy chains representing 
five different isotypes. In each case these heavy chains lacked 
the CH1 domain. The deletion of other Ca domains did not 
appear to prevent the posttranslational association of BiP 
with heavy chains.  This implies that the CH1 domain con- 
tains or contributes to a site necessary for BiP association. 
It is  of interest that  LC are  covalently attached to heavy 
chains at the Cnl domain. It is possible that BiP interacts 
with a portion of the heavy chain that is involved in the as- 
sociation with LC. 
When LC- cell lines were examined, a direct correlation 
was found between the lack of association of BiP with heavy 
chains  and  the  ability  of these  free heavy  chains  to  be 
secreted. Two LC- cell lines (AI5 and G403) were exam- 
ined here that produced heavy chains that did not associate 
with BiP and were secreted. In both cases, the heavy chains 
contained  deletions  of  the  CH1  domain.  This  situation 
closely parallels that seen in human HCD where free mutant 
heavy chains are secreted. These mutant heavy chains con- 
tain  large  deletions that  usually  include the  CH1  domain 
(25). We have shown that human lymphoid cell lines also 
produce BiP which associates with heavy chains in much the 
same fashion as  in mouse cell lines  (Hendershot, L.,  D. 
Bole, and J. E  Kearney, manuscript submitted for publica- 
tion). It is, therefore, very tempting to suggest that the inabil- 
ity of HCD proteins to associate with BiP is responsible for 
the secretion of free heavy chains in this disease. 
Biosynthetic studies of pre-B hybridomas and LC- mye- 
lomas have demonstrated that free heavy chains are not nor- 
mally secreted from lymphoid cells (17, 23). It has been sug- 
gested that heavy chains  do not contain transport signals 
necessary for targeting them to the Golgi and that the trans- 
port signals are on the LC (28). Only after combination with 
LC would heavy chains be transported. However, the secre- 
tion of mutant heavy chains in HCD and in certain LC- cell 
lines suggests that heavy chains do contain transport signals 
(21, 25).  The two LC- cell lines examined here (A15 and 
G403),  which  secrete  free heavy  chains,  produce  heavy 
chains that do not associate with BiP. This strengthens our 
hypothesis that BiP either obscures the transport signals in- 
herent to heavy chains or prevents the formation of cryptic 
transport signals (6). Only after BiP is displaced by LC or 
when it is unable to bind (in the case of Cel domain mu- 
tants)  would  heavy  chain  transport  signals  be  exposed, 
resulting in the transport of heavy chains to the Golgi. 
The examination oflg assembly and secretion in 10.1 cells 
(CHI-, LC  ÷) contributes to our understanding of the role of 
BiP in preventing heavy chain secretion. The fact that some 
complete assembly of Ig occurred demonstrates that BiP is 
not necessary for assembly of  heavy and light chains. But the 
finding that unassembled and assembling heavy chains can 
be secreted, even in the presence of LC synthesis and assem- 
bly, is perhaps the most compelling evidence that BiP acts 
to prevent the  secretion of unassembled heavy chains.  In 
most cases, heavy chains are only secreted as intact H2L2 
molecules.  It  is  noteworthy  that  a  trace  amount  of HL 
molecules are secreted from 45.6 cells. A portion of Ig as- 
sembly in this cell line follows the H  "" HL --" H2L2 path- 
way. We have found that the HL molecule in this cell line is 
not associated with BiP (unpublished data). Previous studies 
have shown that mutant IgA molecules that cannot form in- 
terchain H-H bond are secreted as HL molecules (30). This 
might be interpreted to suggest that any Ig intermediate not 
associated with BiP is capable of being secreted. It is also 
noteworthy that the heavy chains  from the  10.1 cell line, 
which do not associate with BiP, are secreted at a faster rate 
than their normal counterparts. This suggests that associa- 
tion with BiP might delay heavy chain transport until assem- 
bly with LC is complete. 
When examining IgM mutants, we found that the absence 
of the CH1 domain did not entirely prevent the association 
of IX heavy chains with BiP.  A very weak association of IX 
heavy chains with BiP remained in 427 (18) and 128 (2) cells, 
which are missing the Ca 1 and Cn2 domains,  and 43 (18) 
ceils,  which are lacking the CH1  domain.  This suggests a 
second domain with the ability to associate weakly with BiP. 
This association could only be observed after overexposure 
of gels  even in  LC- mutants  (unpublished data).  It is in- 
teresting that only the IX heavy chains appear to have a second 
(albeit weak)  site for BiP association.  When the CH1  and 
CH2 domain of IX chains were absent, LC were able to form 
disulfide bonds with the CH3 or CH4 domains (18).  How- 
ever, when the CH1 domain is missing from a  or y heavy 
chains, the LC can only form noncovalent bonds with the 
CH2 or Ce3 domain. It is possible that BiP interacts with ei- 
ther the free sulfhydryl involved in H-L bond formation or 
a hydrophobic region of the C~I domain, which is eventu- 
ally covered by the constant domain of the LC (9, 16). Both 
of these must be duplicated in the IX heavy chains since there 
is a second site for LC attachment. However, the fact that 
BALB/c ¢t heavy chains (1) and human ¢t2 heavy chains (15) 
both have mutations, which change the heavy chain cysteine 
residue involved in H-L formation but are still able to associ- 
ate with BiP, suggests  that this sulfhydryl is not involved in 
BiP association. 
The data presented here demonstrate that the Cal domain 
of heavy chains is necessary for their association with BiP. 
In the absence of association with BiP, free heavy chains and 
assembling  intermediates of Ig  can be  secreted,  whereas 
heavy chains that associate with BiP are secreted only as 
completely assembled Ig molecules. 
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